Truly Man's Best Friend: Canine Cancers Drive Drug Repurposing in Osteosarcoma

Mia C Weiss1,2, Vanessa Eulo3, Brian A Van Tine1,2,4

  • 1Department of Medicine, Division of Medical Oncology, Washington University in St. Louis, School of Medicine, St. Louis, Missouri.

Insights

Canine osteosarcoma, a common dog bone tumor, offers a unique model for human osteosarcoma research. Studying dogs accelerates drug testing and repurposing for this aggressive cancer.

Area of Science:

  • Comparative oncology
  • Veterinary medicine
  • Translational cancer research

Background:

  • Metastatic osteosarcoma is rare in humans but is the most common primary bone tumor in dogs.
  • Osteosarcoma exhibits significant genetic similarities between canine and human patients.

Discussion:

  • Canine clinical trials provide a valuable platform for rapid drug testing and repurposing in osteosarcoma.
  • This translational approach allows for faster evaluation of therapeutic strategies compared to human-only trials.

Key Insights:

  • Dogs serve as a powerful preclinical model for human osteosarcoma.
  • Genetic parallels enable direct translation of findings from canine studies to human medicine.

Outlook:

  • Accelerated development of novel treatments for osteosarcoma.
  • Enhanced understanding of osteosarcoma biology through comparative oncology.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K